These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20013081)

  • 1. Solid self-microemulsifying formulation for candesartan cilexetil.
    Nekkanti V; Karatgi P; Prabhu R; Pillai R
    AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
    Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
    Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized formulation of solid self-microemulsifying sirolimus delivery systems.
    Cho W; Kim MS; Kim JS; Park J; Park HJ; Cha KH; Park JS; Hwang SJ
    Int J Nanomedicine; 2013; 8():1673-82. PubMed ID: 23641156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.
    Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
    Drug Dev Ind Pharm; 2015; 41(9):1548-57. PubMed ID: 25308746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation.
    Qi X; Qin J; Ma N; Chou X; Wu Z
    Int J Pharm; 2014 Sep; 472(1-2):40-7. PubMed ID: 24929011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of a self-microemulsifying drug delivery system of olmesartan medoxomil for enhanced bioavailability.
    Komesli Y; Burak Ozkaya A; Ugur Ergur B; Kirilmaz L; Karasulu E
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1292-1305. PubMed ID: 30986085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone.
    Cui S; Zhao C; Chen D; He Z
    Drug Dev Ind Pharm; 2005 May; 31(4-5):349-56. PubMed ID: 16093200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of solubility and permeability of Candesartan cilexetil by using different pharmaceutical interventions.
    Shaikh SM; Avachat AM
    Curr Drug Deliv; 2011 Jul; 8(4):346-53. PubMed ID: 21453263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of self-microemulsifying bilayer tablets for pH-independent fast release of candesartan cilexetil.
    Sohn Y; Lee SY; Lee GH; Na YJ; Kim SY; Seong I; Lee BJ; Kuh HJ; Lee J
    Pharmazie; 2012 Nov; 67(11):917-24. PubMed ID: 23210241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
    Bolko K; Zvonar A; Gašperlin M
    Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    J Pharm Sci; 2019 Nov; 108(11):3599-3608. PubMed ID: 31348934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N; Zhang W; Jin Y; Quan DQ
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems.
    Cirri M; Roghi A; Valleri M; Mura P
    Eur J Pharm Biopharm; 2016 Jul; 104():19-29. PubMed ID: 27091783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.